MTVA (MetaVia, Inc.) Expected net earnings per share growth this year
MetaVia Inc develops methods to combat dementia and Parkinson's disease, yet year-over-year EPS changes confirm financial volatility. The 65.60 level records fresh values, highlighting a liquidity deficit due to a lack of sales. Expansion into the obesity and MASH therapy segments through the development of a dual-agonist pipeline to capture market share will serve as the solution.
Analytical breakdowns and data insights for company metaviatx.com (MTVA)
- share price and consensus valuation forecast:
- business market valuation indicators:
- shareholders' equity book value data:
- debt burden and liquidity indicators:
- earnings and market multiples details:
MTVA - Net Income|Expected Profit MetaVia Inc|MTVA - P/E Multiple|Forward P/E Multiple MetaVia|MTVA - Price/Earnings to Growth Ratio|Enterprise Value to Operating Income Before Depreciation MetaVia|MTVA - Operating profit EBITDA|Net earnings per one share for the last twelve months MetaVia|MTVA - Net earnings per share for the last 12 months|Quarterly EPS earnings growth metaviatx.com|MTVA - Earnings per share growth in current year|Expected earnings per share trend next year MetaVia Inc
Fundamental valuation:MTVA, MetaVia, Inc.
Asset managers require an objective assessment of an issuer's yield dynamics to minimize risks. This indicator captures the rate of change in earnings per share relative to the same period last year. By analyzing the EPS YoY percentage shift, an investor identifies phases of consolidation or growth in fundamental value. For MetaVia Inc (MTVA), this metric reflects the cost efficiency of neurotherapy. A positive trend would confirm the successful commercialization of AI-driven drugs for the treatment of cognitive disorders.
Main competitors
BIIB (Biogen Inc) - Earnings per share growth in current year|NBIX (Neurocrine Biosciences Inc) - Earnings growth in current year|Regencell Corp (RGC) - Expected net earnings per share growth this year|Earnings growth in current year AXSM|Earnings growth in current year acadia-pharm.com (ACAD)|Xenon - Net earnings per share growth this year|Earnings per share increase in current year VKTX|Supernus Pharma - Earnings growth in current year|Expected net earnings per share growth this year Catalyst Corp CPRX|Denali Therapeutics (DNLI) - Earnings per share growth in current year|Earnings per share growth this year HRMY|BHVN (Biohaven) - Earnings growth in current year|Net earnings per share growth this year Amylyx Pharmaceuticals Inc (AMLX)|Earnings per share growth in current year Trevi Pharma (TRVI)|Net earnings per share growth this year Praxis Corp PRAX|Anavex Life Sciences - Net earnings per share growth this year|Net earnings per one share growth for the current year CBLL (ceribell.com)|PRTA: Net earnings per share growth this year|ALEC: Earnings per share growth in current year|ANNX: Earnings growth in current year|Omeros (OMER) - Earnings growth in current year|Earnings per share growth in current year Neurogene Inc.|Earnings per share growth this year ACIU (acimmune.com)|Earnings growth in current year VYGR|NMRA - Earnings per share growth rate in current year|Scilex Holding Co. - Net earnings per share growth this year|Earnings growth in current year Tevogen Bio Inc. TVGN|ACOG - Earnings per share growth in current year|Earnings per share increase in current year CGTX (Cognition Therapeutics Inc.)|Inhibikase Therapeutics, Inc. (IKT) - Earnings per share growth in current year|Earnings per share growth rate in current year Cassava Sciences Inc (SAVA)|Earnings per share growth in current year Assertio Holdings|Net earnings per share growth this year Coya (COYA)|Earnings growth in current year VTGN|OVID - Earnings per share growth rate in current year|Acumen Pharmaceuticals, Inc. - Net earnings per share growth this year|Net earnings per one share growth for the current year CRVO (CervoMed, Inc.)|Alterity Therapeutics Ltd - Earnings growth in current year|CLNN - Earnings growth in current year|PEPG (pepgen.com) - Net earnings per share growth this year|JUNS (Jupiter Neurosciences, Inc.) - Earnings per share growth in current year|RLMD (Relmada Therapeutics, Inc.) - Earnings growth in current year|Annovis Bio Inc (ANVS) - Expected net earnings per share growth this year|Earnings growth in current year GRCE|Earnings growth in current year Firefly Neuro (AIFF)|Klotho Neurosciences - Net earnings per share growth this year|Earnings per share increase in current year NRSN|Reviva Pharmaceuticals Holdings, Inc. - Earnings growth in current year|Expected net earnings per share growth this year NeurAxis Inc. NRXS|heliusmedical.com (HSDT) - Earnings per share growth in current year|Earnings per share growth this year PASG|NEUP (Neuphoria Therapeutics, Inc.) - Earnings growth in current year|Net earnings per share growth this year minervaneurosciences.com (NERV)|Earnings per share growth in current year Athira Pharma (ATHA)|Net earnings per share growth this year Addex Therapeutics Ltd. ADXN|Alzamend Neuro - Net earnings per share growth this year|Net earnings per one share growth for the current year CYCN (Cyclerion Therapeutics Inc.)|PTIX: Net earnings per share growth this year|KTTA: Earnings per share growth in current year|CRGT: Earnings growth in current year|Avenue Therapeutics Inc. (ATXI) - Earnings growth in current year|Earnings per share growth in current year Brainstorm Cell Therapeutics, Inc.|Earnings per share growth this year CARA (Cara Therapeutics Inc)|Earnings growth in current year CHRO|ELYM - Earnings per share growth rate in current year|Intra-Cellular Therapies, Inc. - Net earnings per share growth this year|Earnings growth in current year Longboard Pharmaceuticals Inc LBPH|MRNS - Earnings per share growth in current year|Earnings per share increase in current year NKGN (NKGen Biotech Corp)|NeuroBo Pharmaceuticals (NRBO) - Earnings per share growth in current year|Earnings per share growth rate in current year sagerx.com (SAGE)|Earnings per share growth in current year Synaptogenix|Net earnings per share growth this year Trevena Inc. (TRVN)|Earnings growth in current year VIGL|WENA - Earnings per share growth rate in current year|Cerevel Therapeutics - Net earnings per share growth this year
